Annette M. Jackson
Duke Department of Surgery, Duke University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Annette M. Jackson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05017545 · Carfilzomib and Belatacept for DesensitizationNational Institute of Allergy and Infectious Diseases (NIAID) · active not recruiting · Highly Sensitized Prospective Kidney Transplant Recipients · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant RecurrenceU01AI152585 · NIAID · DUKE UNIVERSITY · fiscal years 2020 to 2024 · $650,335 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:38 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- 303 citationsRCR 14.9
- Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study.Am J Transplant · 2016138 citationsRCR 5.5
- Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.Circulation · 2020136 citationsRCR 6.0
- Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.Eur Heart J · 2021129 citationsRCR 8.2
- Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.Eur J Heart Fail · 202266 citationsRCR 4.7
- Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.Circ Heart Fail · 202165 citationsRCR 3.7
- Cyclical micromovement and fracture healing.J Bone Joint Surg Br · 199549 citationsRCR 3.0
- Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.Eur J Heart Fail · 202239 citationsRCR 2.8
- IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.Am J Transplant · 202025 citationsRCR 1.4
- Validation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational study.Biomarkers · 201823 citationsRCR 1.0